Literature DB >> 123191

Evidence of subclinical heart muscle dysfunction in acromegaly.

E A Jonas, J F Aloia, F J Lane.   

Abstract

A group of ten acromegalic patients, who had no history of heart failure, was studied to determine whether subtle carciac impairment may also be common. None had clinical evidence of coronary artery disease or severe hypertension. Systolic time intervals were recorded in each patient and compared with normal values predicted for sex and heart rate by our own controls and published data. The results indicate that measurable abnormalities in left ventricular performance are common in this sampling. Known duration and activity of disease (growth hormone levels at time of study) did not correlate with the time intervals. The results are consistent with cardiomyopathic effect of excessive growth hormone.

Entities:  

Mesh:

Year:  1975        PMID: 123191     DOI: 10.1378/chest.67.2.190

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Doppler echocardiographic patterns in patients with acromegaly.

Authors:  M Terzolo; L Avonto; C Matrella; R Pozzi; S Luceri; G Borretta; F Pecchio; G Ugliengo; G P Magro; G Reimondo
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Cardiomegaly and abdominal mass in an acromegalic patient.

Authors:  R Simó; J Mesa; G Obiols; E Domingo; J Lupon-Rosés
Journal:  Int J Card Imaging       Date:  1987

3.  Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features.

Authors:  M Terzolo; C Matrella; A Boccuzzi; S Luceri; M Borriero; G Reimondo; A Pia; E Rovero; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

4.  Acromegalic cardiopathy improves after treatment with increasing doses of octreotide.

Authors:  J L Pereira; M J Rodriguez-Puras; A Leal-Cerro; A Martinez; P P Garcia-Luna; I Gavilan; A Pumar; R Astorga
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

5.  Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle.

Authors:  J Timsit; B Riou; J Bertherat; C Wisnewsky; N S Kato; A S Weisberg; J Lubetzki; Y Lecarpentier; S Winegrad; J J Mercadier
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Acromegalic cardiopathy: a left ventricular scintigraphic study.

Authors:  N Sicolo; F Bui; M Sicolo; L Varotto; C Martini; C Macor; G Federspil
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

7.  Heart size and function in acromegaly.

Authors:  H M Mather; M J Boyd; J S Jenkins
Journal:  Br Heart J       Date:  1979-06

Review 8.  Diabetes and arterial hypertension.

Authors:  P L Drury
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

9.  Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle.

Authors:  E A Rodrigues; M P Caruana; A Lahiri; J D Nabarro; H S Jacobs; E B Raftery
Journal:  Br Heart J       Date:  1989-09

Review 10.  Recent developments in acromegaly: a review.

Authors:  A Jadresic
Journal:  J R Soc Med       Date:  1983-11       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.